Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Does the Metal-Fatigue Principle Apply to Elderly Bones?

Mary Beth Nierengarten  |  Issue: August 2018  |  August 16, 2018

“We don’t think of bone in the way we think of the brain, so intricately connected with cellular communication,” he says. “But in reality, what the research is beginning to show us with this connection between cells is the idea that the osteocyte, that particular cell that is most plentiful within the bone, may be the regulator of osteoclasts and osteoblasts.”

Identifying how cells within bones communicate is important for expanding prevention and treatment options beyond the use of current therapies, such as bisphosphonates, that only target the cells responsible for bone removal.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

By identifying cyclic loading of weight-bearing bones as a mechanism of fracture due to the damage of microcracks over time, the research points to the importance of developing therapies that will also target cells in the bone responsible for bone quality—or those cells that help bones withstand loading or stress.

“It is now recognized that osteocyte cells are playing a bigger role than we thought,” says Dr. Acevedo.

Dr. Vail

Dr. Vail

For Dr. Vail, this broader understanding of the mechanisms of skeletal pathology is getting at what he says is the core of the problem—how to identify patients at risk of fracture and prevent an additional fracture in people after a fracture. “It is my sense that there are other opportunities to enhance a healthy skeleton more than we currently know about how the skeleton repairs itself and communicates with itself,” he says.

The current research points to a plausible new way to look at fracture risk and subsequently expanding thinking on potential new targets for treatment.

Arvind Nana, MD, an orthopedic surgeon in Fort Worth, Texas, however, questions the plausibility of fractures caused by microcracks in aging bones that over time weaken the bone and make it susceptible to fracture. Saying that such fragility fractures do seem plausible in compression fractures of the spine, he does not think these types of microcracks are commonly seen in hip fracture.

“If cyclic loading is the cause of a fracture, it most likely would be in the spine,” he says, adding that most hip fractures he sees are due to falls and rarely occur in people who say their hip just gave out.

Although Dr. Nana is primarily a trauma orthopedic surgeon and, therefore, sees patients who have fracture due to trauma, but as medical director of a geriatric hip fracture program in Fort Worth, he also sees a large number of hip fractures in older patients.

Page: 1 2 3 | Single Page
Share: 

Filed under:Conditions Tagged with:bonebone breakbone remodelingFractures

Related Articles

    Osteoporosis Experts Discuss Bisphosphonate Holidays

    November 24, 2020

    ACR CONVERGENCE 2020—Bisphosphonates are an important treatment for millions of older Americans with osteoporosis because the drugs inhibit osteoclastic bone resorption to reduce the risk of painful, debilitating fractures.1 More than 20 years ago, data emerged that bisphosphonates have a long terminal half-life.2 So after years of therapy, could some patients take a drug holiday?…

    Unexpected Benefits of Bisphosphonates after Hip Fracture

    February 3, 2012

    Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

    Build Up Bone

    June 1, 2007

    Current management of osteoporosis

    Reading Rheum

    March 1, 2007

    Handpicked Reviews of Contemporary Literature

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences